Belite Bio (BLTE) Current Leases (2022 - 2025)
Belite Bio (BLTE) recorded quarterly Current Leases of $241000.0 in Q4 2025, down 9.06% quarter-over-quarter from $265000.0 in Q3 2025, and down 12.68% on a YoY basis from $276000.0 in Q4 2024.
Belite Bio (BLTE) Current Leases (2022 - 2025) Analysis & Trends
Belite Bio's Current Leases history runs 4 years deep, the most recent figure standing at $241000.0 for Q4 2025.
- In Q4 2025, Current Leases fell 12.68% year-over-year to $241000.0; the TTM figure through Dec 2025 stood at $241000.0 (down 12.68% YoY), while the FY2025 annual figure was $241000.0, down 12.68% from the prior year.
- Current Leases was $241000.0 for Q4 2025 at Belite Bio, down from $265000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $308000.0 in Q4 2023 to a low of -$228000.0 in Q3 2024.
- Historically, Current Leases has averaged $176666.7 across 4 years, with a median of $253000.0 in 2025.
- Biggest YoY gain for Current Leases was 216.23% in 2025; the steepest drop was 12.68% in 2025.
- A 4-year view of Current Leases shows it stood at $198000.0 in 2022, then soared by 55.56% to $308000.0 in 2023, then retreated by 10.39% to $276000.0 in 2024, then declined by 12.68% to $241000.0 in 2025.
- The last three Current Leases figures came in at $241000.0 (Q4 2025), $265000.0 (Q3 2025), and $276000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 720.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 241,000.00 |
| Sep 30, 2025 | 265,000.00 |
| Dec 31, 2024 | 276,000.00 |
| Sep 30, 2024 | -228,000.00 |
| Dec 31, 2023 | 308,000.00 |
| Dec 31, 2022 | 198,000.00 |